The U.S. Food and Drug Administration has granted an Emergency Use Authorization for a COVID-19 antibody therapy developed by Indianapolis-based Eli Lilly and Co. (NYSE: LLY).
Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has reached an initial agreement with the U.S. government to supply 300,000 vials of its investigational antibody treatment for COVID-19.
The city of Indianapolis has begun accepting applications for a grant program designed to help local restaurants, bars, and entertainment venues
If you have a loved one in need [...]
Indianapolis-based Eli Lilly and Co. (NYSE: LLY) and Amgen Inc. (Nasdaq: AMGN) are collaborating on the manufacturing of potential COVID-19 therapies.
INDIANAPOLIS (WISH) — Indiana health officials don't want [...]
(WISH) – A member of the White House [...]
The city of Shelbyville is upping the ante on providing assistance for small businesses during the COVID-19 pandemic.
A recently-completed study from the Indiana University School of Medicine shows asymptomatic COVID-19 infection is possible in children under the age of 10.
General Motors Co. (NYSE: GM) says it will soon hand over operational control of its Kokomo plant to Washington-based Ventec Life Systems.